516 research outputs found

    The Anti-Theatrical Prejudice and the Quakers

    Full text link
    Today\u27s Quakers are considerably less hard-shelled and mole-eyed and there are signs on both sides of the Atlantic that the Society of Friends has made progress toward making peace with the theatre. Indeed, one could argue that the situation has changed radically in the last three hundred fifty years, but there remains an ambiguity at best, an antipathy at worst, between Quaker thought and the theatre. This topic is too broad to be encompassed within the limits of this essay, which can merely open doors slightly to a subject that should be treated in more depth at another time and place. Accordingly, this essay will only survey and illustrate the changes in Quaker position toward the theatre and suggest some of their implications. Specifically, it will attempt two things: (1) to sketch historically the development of Quaker attitudes toward the theatre prior to the 1960\u27s, and (2) to document some of the changes in attitude since 1960

    Stephen Crisp\u27s Short History as Spiritual Journey

    Full text link

    Book Reviews

    Full text link

    Poems

    Full text link
    Poems include: Pie in the SkyThe Iconoclast Has His Da

    Robert Barclay and the Rhetoric of the Inward Light

    Full text link

    A higher order perfectly matched layer formulation for finite-difference time-domain seismic wave modeling

    Get PDF
    We have developed a higher order perfectly matched layer (PML) formulation to improve the absorption performance for finite-difference time-domain seismic modeling. First, we outlined a new unsplit “correction” approach, which allowed for traditional, first-order PMLs to be added directly to existing codes in a straightforward manner. Then, using this framework, we constructed a PML formulation that can be used to construct higher order PMLs of arbitrary order. The greater number of degrees of freedom associated with the higher order PML allow for enhanced flexibility of the PML stretching functions, thus potentially facilitating enhanced absorption performance. We found that the new approach can offer increased elastodynamic absorption, particularly for evanescent waves. We also discovered that the extra degrees of freedom associated with the higher order PML required careful optimization if enhanced absorption was to be achieved. Furthermore, these extra degrees of freedom increased the computational requirements in comparison with first-order schemes. We reached our formulations using one compact equation thus increasing the ease of implementation. Additionally, the formulations are based on a recursive integration approach that reduce PML memory requirements, and do not require special consideration for corner regions. We tested the new formulations to determine their ability to absorb body waves and surface waves. We also tested standard staggered grid stencils and rotated staggered grid stencils

    The DEEP2 Galaxy Redshift Survey: Mean Ages and Metallicities of Red Field Galaxies at z ~ 0.9 from Stacked Keck/DEIMOS Spectra

    Get PDF
    As part of the DEEP2 galaxy redshift survey, we analyze absorption line strengths in stacked Keck/DEIMOS spectra of red field galaxies with weak to no emission lines, at redshifts 0.7 <= z <= 1. Comparison with models of stellar population synthesis shows that red galaxies at z ~ 0.9 have mean luminosity-weighted ages of the order of only 1 Gyr and at least solar metallicities. This result cannot be reconciled with a scenario where all stars evolved passively after forming at very high z. Rather, a significant fraction of stars can be no more than 1 Gyr old, which means that star formation continued to at least z ~ 1.2. Furthermore, a comparison of these distant galaxies with a local SDSS sample, using stellar populations synthesis models, shows that the drop in the equivalent width of Hdelta from z ~ 0.9 to 0.1 is less than predicted by passively evolving models. This admits of two interpretations: either each individual galaxy experiences continuing low-level star formation, or the red-sequence galaxy population from z ~ 0.9 to 0.1 is continually being added to by new galaxies with younger stars.Comment: A few typos were corrected and numbers in Table 1 were revise

    Irreversible transformation of ferromagnetic ordered stripe domains in single-shot IR pump - resonant X-ray scattering probe experiments

    Full text link
    The evolution of a magnetic domain structure upon excitation by an intense, femtosecond Infra-Red (IR) laser pulse has been investigated using single-shot based time-resolved resonant X-ray scattering at the X-ray Free Electron laser LCLS. A well-ordered stripe domain pattern as present in a thin CoPd alloy film has been used as prototype magnetic domain structure for this study. The fluence of the IR laser pump pulse was sufficient to lead to an almost complete quenching of the magnetization within the ultrafast demagnetization process taking place within the first few hundreds of femtoseconds following the IR laser pump pulse excitation. On longer time scales this excitation gave rise to subsequent irreversible transformations of the magnetic domain structure. Under our specific experimental conditions, it took about 2 nanoseconds before the magnetization started to recover. After about 5 nanoseconds the previously ordered stripe domain structure had evolved into a disordered labyrinth domain structure. Surprisingly, we observe after about 7 nanoseconds the occurrence of a partially ordered stripe domain structure reoriented into a novel direction. It is this domain structure in which the sample's magnetization stabilizes as revealed by scattering patterns recorded long after the initial pump-probe cycle. Using micro-magnetic simulations we can explain this observation based on changes of the magnetic anisotropy going along with heat dissipation in the film.Comment: 16 pages, 6 figure

    BIRC6 mediates imatinib resistance independently of Mcl-1

    Get PDF
    © 2017 Okumu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Baculoviral IAP repeat containing 6 (BIRC6) is a member of the inhibitors of apoptosis proteins (IAPs), a family of functionally and structurally related proteins that inhibit apoptosis. BIRC6 has been implicated in drug resistance in several different human cancers, however mechanisms regulating BIRC6 have not been extensively explored. Our phosphoproteomic analysis of an imatinib-resistant chronic myelogenous leukemia (CML) cell line (MYL-R) identified increased amounts of a BIRC6 peptide phosphorylated at S480, S482, and S486 compared to imatinib-sensitive CML cells (MYL). Thus we investigated the role of BIRC6 in mediating imatinib resistance and compared it to the well-characterized anti-apoptotic protein, Mcl-1. Both BIRC6 and Mcl-1 were elevated in MYL-R compared to MYL cells. Lentiviral shRNA knockdown of BIRC6 in MYL-R cells increased imatinib-stimulated caspase activation and resulted in a ~20-25-fold increase in imatinib sensitivity, without affecting Mcl-1. Treating MYL-R cells with CDK9 inhibitors decreased BIRC6 mRNA, but not BIRC6 protein levels. By contrast, while CDK9 inhibitors reduced Mcl-1 mRNA and protein, they did not affect imatinib sensitivity. Since the Src family kinase Lyn is highly expressed and active in MYL-R cells, we tested the effects of Lyn inhibition on BIRC6 and Mcl-1. RNAi-mediated knockdown or inhibition of Lyn (dasatinib/ponatinib) reduced BIRC6 protein stability and increased caspase activation. Inhibition of Lyn also increased formation of an N-terminal BIRC6 fragment in parallel with reduced amount of the BIRC6 phosphopeptide, suggesting that Lyn may regulate BIRC6 phosphorylation and stability. In summary, our data show that BIRC6 stability is dependent on Lyn, and that BIRC6 mediates imatinib sensitivity independently of Mcl-1 or CDK9. Hence, BIRC6 may be a novel target for the treatment of drugresistant CML where Mcl-1 or CDK9 inhibitors have failed
    corecore